Everybody Is Invited to Overeaters Anonymous’ Biggest Birthday Bash
Increase and own your freedom from food and body obsession and celebrate with us!Please join us for OA's 64th Annual...
Day: December 13, 2023
Newly Launched ClarityHLTH Revolutionizes Telehealth: Compare and Choose with Ease
ClarityHLTH is Devoted to Helping Provide Online Health Transparency to ConsumersBOSTON, MA / ACCESSWIRE / December 13, 2023 / On...
Sibannac, Inc. to Enter into Manufacturing Agreement with Major Extraction Partner for Onsite Oil Production
Scottsdale, Arizona--(Newsfile Corp. - December 13, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Safe Supply Streaming Announces Shares for Debt and Options Issuance
Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) ("Safe Supply" or...
Omni-Biotic AB 10 Probiotic Wins Practitioner’s Choice Award
NEW YORK, NY / ACCESSWIRE / December 13, 2023 / AllergoSan USA is thrilled to announce that their Omni-Biotic AB...
ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
CHICAGO, IL / ACCESSWIRE / December 13, 2023 / The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the...
AgriCann Announces Resignation of Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - December 13, 2023) - AgriCann Solutions Corp. ("AgriCann") (with its subsidiaries, collectively referred to as...
1 in 3 Primary Care Physicians Have Already Tried AI Scribe Tools, Outlook Is Cautiously Optimistic, Finds Elation Health Survey
Survey of more than 200 clinicians highlights optimism about improvements to physician and patient experiences while pointing out some early...
Blue Cross and Blue Shield of Minnesota Initiative Awards $1M Annually to Reduce and Eliminate Access to and Use of Commercial Tobacco
Blue Cross' Center for Prevention will support six organizations and one Tribal nation to reduce commercial tobacco use in disproportionately...
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication...
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication...
Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer
Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT...
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees
VINIA Superfood Coffee will be a unique disruptor in the $6B US coffee pod marketFirst of three Major "VINIA Inside"...
Justera Introduces K-Beauty Online Store
Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")...
Lynx.MD and Baptist Health Innovations Collaborate to Advance Medical Research and Development
Initiative enhances Baptist Health South Florida's efforts in medical innovation for advanced research and collaborative development.PALO ALTO, CA / ACCESSWIRE...
Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer
Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT...
Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell...
SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET
NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a...
Protagonist Earns $10 Million Payment for Achievement of Clinical Milestone in Phase 2b ANTHEM-UC Study of JNJ-2113 in Adults with Moderately to Severely Active Ulcerative Colitis
NEWARK, CA / ACCESSWIRE / December 13, 2023 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced it has...
Research for the Treatment of a ‘Black Sheep’ Cancer Moves to Human Clinical Trials
With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a...